Darmiyan
Coming January 25

What's Next In Brain Health

Date & Time


January 25, 12:00 PM ET / 9:00 AM PT
Webinar: Details provided upon RSVP approval

About the Event


Mr. Hamid Moghadam is the co-Founder, Chairman and CEO of Prologis, the global leader in logistics real estate and a member of the S&P 100.  He is a Trustee Emeritus of Stanford University and Chairman Emeritus of the Stanford Management Company. In its latest ranking, Harvard Business Review voted him as the #17 Best Performing CEO in the world. 

As someone who knows what it takes to build a company and use data and technology to transform an industry, Mr. Moghadam imagines a profitable future for Darmiyan and its CEO Padideh Kamali-Zare.

Darmiyan, developers of the world’s 1st AI-powered imaging analysis technology that detects changes in the brain with potential to result in neurodegeneration, offers a paradigm shift for brain health screening and  monitoring.  Armed with new powerful knowledge from readily available brain MRI, physicians can develop targeted treatment plans that can help improve care, reduce heartache, and save billions of dollars.

Join our webinar to hear Mr. Moghadam and Padideh Kamali-Zare, PhD discuss how this new technology can be a great investment by transforming decision making and creating new opportunities.

Register


SHARE THIS EVENT
Share on facebook
Share on twitter
Share on linkedin

All statements and expressions are the sole opinion of the company and are subject to change without notice. The Company is not liable for any investment decisions by its readers or subscribers. It is strongly recommended that any purchase or sale decision be discussed with a financial advisor, or a broker-dealer, or a member of any financial regulatory bodies. The information contained herein has been provided as an information service only. The accuracy or completeness of the information is not warranted and is only as reliable as the sources from which it was obtained. Investors are cautioned that they may lose all or a portion of their investment in this or any other company. Information contained herein contains “forward looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities and Exchange Act of 1934, as amended. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical facts and may be “forward looking statements”. Forward looking statements are based on expectations, estimates and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of words such as “expects”, “will”, “anticipates”, “estimates”, “believes”, or by statements indicating certain actions “may”, “could”, “should” or “might” occur.